These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8815169)
41. Carnitine palmitoyltransferase deficiency: a common cause of recurrent myoglobinuria. Sadeh M; Gutman A Isr J Med Sci; 1990 Sep; 26(9):510-5. PubMed ID: 2228562 [TBL] [Abstract][Full Text] [Related]
42. A case of CPT deficiency, homoplasmic mtDNA mutation and ragged red fibers at muscle biopsy. Sciacco M; Prelle A; Fagiolari G; Bordoni A; Crimi M; Di Fonzo A; Ciscato P; Lamperti C; D'Adda E; Jann S; Bresolin N; Comi GP; Moggio M J Neurol Sci; 2005 Dec; 239(1):21-4. PubMed ID: 16168441 [TBL] [Abstract][Full Text] [Related]
43. [Recurrent paroxysmal myoglobinuria with acute renal insufficiency caused by muscular carnitine (palmitoyltransferase deficiency. A case]. Meunier J; Perrot D; Bret M; Pissere-Meunier J; Bouletreau P; Pasquier J; Carrier H; Berthillier G Nouv Presse Med; 1982 Sep; 11(37):2767-71. PubMed ID: 7145668 [TBL] [Abstract][Full Text] [Related]
44. Cause of recurrent rhabdomyolysis, carnitine palmitoyltransferase II deficiency and novel pathogenic mutation. Çakar NE; Gör Z; Yeşil G Ideggyogy Sz; 2021 Mar; 74(3-4):135-138. PubMed ID: 33938664 [TBL] [Abstract][Full Text] [Related]
45. Acute renal failure due to carnitine palmitoyltransferase deficiency. Berkman N; Meirow D; Katzir Z; Bar-On H J Intern Med; 1993 Mar; 233(3):295-7. PubMed ID: 8450300 [TBL] [Abstract][Full Text] [Related]
46. Recurrent post-infectious rhabdomyolysis in muscle CPT-II deficiency caused by a novel missense mutation. van den Ameele J; Van Landegem W; Wuyts W; De Bleecker J Acta Neurol Belg; 2008 Dec; 108(4):155-60. PubMed ID: 19239046 [TBL] [Abstract][Full Text] [Related]
47. Metabolic causes of myoglobinuria. Tonin P; Lewis P; Servidei S; DiMauro S Ann Neurol; 1990 Feb; 27(2):181-5. PubMed ID: 2156480 [TBL] [Abstract][Full Text] [Related]
48. The diagnosis of carnitine palmitoyltransferase II deficiency is now possible in small skeletal muscle biopsies. Hargreaves IP; Heales SJ; Olpin SE; Morgan-Ughes JA; Land JM J Inherit Metab Dis; 2000 Jun; 23(4):352-4. PubMed ID: 10896292 [No Abstract] [Full Text] [Related]
49. [Rhabdomyolysis and myoglobinuria]. Lindner A; Zierz S Nervenarzt; 2003 Jun; 74(6):505-15. PubMed ID: 12799789 [TBL] [Abstract][Full Text] [Related]
50. Combined partial deficiency of muscle carnitine palmitoyltransferase and carnitine with autosomal dominant inheritance. Ionasescu V; Hug G; Hoppel C J Neurol Neurosurg Psychiatry; 1980 Aug; 43(8):679-82. PubMed ID: 7431028 [TBL] [Abstract][Full Text] [Related]
51. Carnitine palmitoyltransferase type 2 deficiency: novel mutation in a Native South American family with whole-body muscle magnetic resonance imaging findings: two case reports. Avila-Smirnow D; Boutron A; Beytía-Reyes MLÁ; Contreras-Olea O; Caicedo-Feijoo A; Gejman-Enríquez R; Escobar-Henríquez R; Förster-Mujica J J Med Case Rep; 2018 Aug; 12(1):249. PubMed ID: 30149802 [TBL] [Abstract][Full Text] [Related]
52. Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: functional analysis and association with polymorphic haplotypes and two clinical phenotypes. Wataya K; Akanuma J; Cavadini P; Aoki Y; Kure S; Invernizzi F; Yoshida I; Kira J; Taroni F; Matsubara Y; Narisawa K Hum Mutat; 1998; 11(5):377-86. PubMed ID: 9600456 [TBL] [Abstract][Full Text] [Related]
53. A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency. Deschauer M; Wieser T; Schröder R; Zierz S Mol Genet Metab; 2002 Feb; 75(2):181-5. PubMed ID: 11855939 [TBL] [Abstract][Full Text] [Related]
54. Carnitine palmitoyltransferase II deficiency: diagnosis by molecular analysis of blood. Kaufmann P; el-Schahawi M; DiMauro S Mol Cell Biochem; 1997 Sep; 174(1-2):237-9. PubMed ID: 9309694 [TBL] [Abstract][Full Text] [Related]
55. Carnitine palmitoyltransferase-II deficiency: case presentation and review of the literature. Mccormick BJ; Chirila RM Rom J Intern Med; 2021 Dec; 59(4):420-424. PubMed ID: 34118800 [TBL] [Abstract][Full Text] [Related]
56. Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency. Yasuno T; Osafune K; Sakurai H; Asaka I; Tanaka A; Yamaguchi S; Yamada K; Hitomi H; Arai S; Kurose Y; Higaki Y; Sudo M; Ando S; Nakashima H; Saito T; Kaneoka H Biochem Biophys Res Commun; 2014 May; 448(2):175-81. PubMed ID: 24780397 [TBL] [Abstract][Full Text] [Related]
57. Selective carnitine palmitoyltransferase deficiency in fibroblasts from a patient with muscle CPT deficiency. Pula TP; Max SR; Zielke HR; Chacon M; Baab P; Gumbinas M; Reed WD Ann Neurol; 1981 Aug; 10(2):196-8. PubMed ID: 7283405 [TBL] [Abstract][Full Text] [Related]
58. Myopathy due to carnitine palmitoyltransferase II deficiency: updating genetic aspects of the first publication in Brazil. Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Rodrigues PRDVP; Arndt RC; Scola RH; Werneck LC Arq Neuropsiquiatr; 2024 Feb; 82(2):1-4. PubMed ID: 38395422 [TBL] [Abstract][Full Text] [Related]
59. Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria. Bruno C; Minetti C; Shanske S; Morreale G; Bado M; Cordone G; DiMauro S Neurology; 1998 Jan; 50(1):296-8. PubMed ID: 9443500 [TBL] [Abstract][Full Text] [Related]
60. Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency. Joshi PR; Deschauer M; Zierz S Wien Klin Wochenschr; 2012 Dec; 124(23-24):851-4. PubMed ID: 23184072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]